Copyright
©The Author(s) 2023.
World J Meta-Anal. Apr 18, 2023; 11(4): 125-133
Published online Apr 18, 2023. doi: 10.13105/wjma.v11.i4.125
Published online Apr 18, 2023. doi: 10.13105/wjma.v11.i4.125
Ref. | Country | Study design | Sample size | Sex | Baricitinib group | Non-baricitinib group | |||
Male | Female | Number of patients | Death | Number of patients | Death | ||||
Hasan et al[14], 2021 | Bangladesh | Cohort study | 238 | 159 | 79 | 122 | 4 | 116 | 7 |
Stebbing et al[15], 2021 | Italy, Spain | Observational | 790 | 438 | 352 | 37 | 1 | 142 | 47 |
Rodriguez-Garcia et al[16], 2020 | Spain | Cohort study | 112 | 78 | 34 | 62 | 5 | 50 | 2 |
Rosas et al[19], 2020 | Spain | Case control study | 29 | 20 | 9 | 12 | 2 | 17 | 6 |
- Citation: Thakur M, Babu A, Khatik GL, Datusalia AK, Khatri R, Kumar A. Role of baricitinib in COVID-19 patients: A systematic review and meta-analysis. World J Meta-Anal 2023; 11(4): 125-133
- URL: https://www.wjgnet.com/2308-3840/full/v11/i4/125.htm
- DOI: https://dx.doi.org/10.13105/wjma.v11.i4.125